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Bougie and colleagues systematically reviewed the current literature on the association 
between race/ethnicity and endometriosis diagnosis (Bougie et al. BJOG 2019 xxxx). 
Compared to white women, black women were less likely (OR:0.49, 95% CI:0.29-0.83) 
(studies=16) and Asian women were more likely to be diagnosed with endometriosis 
(OR:1.63, 95% CI:1.02-2.58) (studies=10). The data suggested that Hispanic women were 
less likely to be diagnosed with endometriosis compared to white women, with a similar 
magnitude of effect as black women, but this finding was not statistically significant 
(OR:0.46, 95% CI: 0.14-1.50) (studies=5). There are many unanswered questions regarding 
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know whether these associations are artifacts of diagnostic biases or whether there is 
heterogeneity in endometriosis phenotype or clinical presentation between racial/ethnic 
groups.  
 
Endometriosis has historically been described as a disease of affluent, high-achieving women 
with private health insurance who delayed marriage and childbearing (Meigs JV. Obstet 
Gynecol. 1953;2:46-53). These early descriptions of endometriosis patients implied a rarity 
of disease in the “non-private patient and, therefore by inference (often stated as such) 
uncommon in black women” (Chatman DL. Am J Obstet Gynecol. 1976;125:987-9), despite 
early research showing no difference between black and white women and suggesting that 
pelvic pain in black women was misdiagnosed (Chatman DL. Am J Obstet Gynecol. 
1976;125:987-9.). In 1979, Buttram wrote, “Typically, our patients with endometriosis 
appear to have an intense desire to excel. They are usually well-dressed and have trim 
figures” (Buttram VC, Jr. Fertil Steril. 1979;31:117-23). While overtly sexist, classist, and 
racist descriptions of endometriosis patients are less common today, these not-so-distant 
views may still consciously or unconsciously influence clinical care leading to disparities in 
endometriosis diagnoses. 
 
Differences in endometriosis diagnoses between black, Asian, Hispanic, and white women 
are likely synergistic with larger systemic problems related to the difficulty of receiving an 
endometriosis diagnosis. Indeed, women globally wait on average seven years between 
endometriosis symptom onset and disease diagnosis, with some women never receiving a 
formal diagnosis. There are numerous factors that contribute to this diagnostic delay 
including inconsistent symptom recognition by both the patient and provider and the lack of a 
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presenting with infertility, disparities for black women attenuated and there was no 
statistically significant difference in endometriosis diagnoses between black, white, and 
Asian patients, suggesting that once patients establish access to clinical care, disparities in 
diagnosis diminish.  
 
Bougie et. al. described substantial heterogeneity (I
2
>50%) between studies. While the 
authors stratified by study year and diagnosis modality, differences in health care access 
across populations also likely contributes to this heterogeneity given the social and economic 
complexities of diagnosis. Different countries will have different medical referral patterns 
and insurance systems, as well as different racial and economic biases. Both race and gender 
have been shown to unconsciously influence referral patterns and clinical care (Schulman KA 
et. al. NEJM. 1999;340:618-26). While future studies investigating the association between 
race/ethnicity in relation to endometriosis are warranted, they must be interpreted through the 
lens of quantifying disparities in access to diagnostic care. We must ensure that women of all 
racial and ethnic backgrounds are comfortable recognising and describing their symptoms 
and that health care providers take these symptoms seriously and provide appropriate and 
timely referral for endometriosis diagnosis and treatment. 
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